Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn

US company is attempting to acquire the maker of a new treatment for pancreatic cancer

capitalindexers
capitalindexers
 Jan 9, 2026  0  2
 Add to Reading List
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn
US company is attempting to acquire the maker of a new treatment for pancreatic cancer
Read More   

Share

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0